STOCKHOLDERS' DEFICIENCY	12 Months Ended
Dec. 31, 2019
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' DEFICIENCY	Preferred Stock - The Company’s certificate of incorporation authorizes its Board to issue up to 1,000,000 shares of preferred stock. The stock is issuable in series that may vary as to certain rights and preferences, as determined upon issuance, and has a par value of $.01 per share. As of December 31, 2019, and 2018, there were no preferred shares issued or outstanding. 2005 Plan - The Company’s Board and stockholders approved a stock option plans adopted in 2005, which has authority to grant options to purchase up to an aggregate of 990,000 common shares at December 31, 2019 (1,030,000 - 2018). 2009 Plan - During 2009, the Company’s Board approved the 2009 stock option plan, which grants options to purchase up to an aggregate of 4,000,000 common shares of which 3,000 common shares are available for grant at December 31, 2019 (348,000 - 2018). Options issued to date are nonqualified since the Company has decided not to seek stockholder approval of the 2009 Plan. 2019 Plan - During 2019, the Company’s Board approved the 2019 stock option plan, which grants options to purchase up to an aggregate of 1,500,000 common shares of which 141,500 common shares are available for grant at December 31, 2019. Options issued to date are nonqualified since the Company has decided not to seek stockholder approval of the 2019 Plan.

STOCKHOLDERS' DEFICIENCY

12 Months Ended

Dec. 31, 2019

Stockholders' Equity Note [Abstract]

Preferred Stock - The Company’s certificate of incorporation authorizes its Board to issue up to 1,000,000 shares of preferred stock. The stock is issuable in series that may vary as to certain rights and preferences, as determined upon issuance, and has a par value of $.01 per share. As of December 31, 2019, and 2018, there were no preferred shares issued or outstanding.

2005 Plan - The Company’s Board and stockholders approved a stock option plans adopted in 2005, which has authority to grant options to purchase up to an aggregate of 990,000 common shares at December 31, 2019 (1,030,000 - 2018).

2009 Plan - During 2009, the Company’s Board approved the 2009 stock option plan, which grants options to purchase up to an aggregate of 4,000,000 common shares of which 3,000 common shares are available for grant at December 31, 2019 (348,000 - 2018). Options issued to date are nonqualified since the Company has decided not to seek stockholder approval of the 2009 Plan.

2019 Plan - During 2019, the Company’s Board approved the 2019 stock option plan, which grants options to purchase up to an aggregate of 1,500,000 common shares of which 141,500 common shares are available for grant at December 31, 2019. Options issued to date are nonqualified since the Company has decided not to seek stockholder approval of the 2019 Plan.